Open access webinar Particle analysis for biopharmaceuticals

Coriolis CTO Dr. Tim Menzen will introduce you to the broad field of particle characterization and discuss real life case studies.

Read More

About us

Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.

As a privately-held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients.

Formulation Development

Formulation Development

“It is a medicine, not a molecule, that we are giving to the patient” Marc B. Brown, 2005.

Coriolis is the expert in developing liquid and lyophilized formulations for a large variety of different (bio)pharmaceutical molecules, including proteins, peptides, nucleic acids, ATMPs, GMOs, vaccines and virus(-like) particles.

Find out how we can support your drug development...

Read more
Analytical Services

Analytical Services

A highly diverse analytical portfolio entirely performed in-house: This is Coriolis.

With the latest in technology and highly experienced scientists, we are a trendsetter in the field. We provide our analytical services for samples up to biosafety level S2 under R&D and cGMP conditions, including method development, qualification and validation.

Get to know our services...

Read more
About us

About us

Independent, reliable and always on the cutting edge of science. Coriolis is a leading service provider for formulation research and development of (bio)pharmaceutical drugs and vaccines.

Get to know us...

Read more

Latest news

Latest publications